Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.
Lunden recounts an interview with Susan M. Love, MD, where she discovered the need for ultrasound, as a result of her dense breast tissue. It was this revelation and procedure that greatly impacted the stage of disease at diagnosis and overall prognosis, Lunden states.
Joan Lunden will be delivering the keynote address at the 32nd Miami Breast Cancer Conference. To attend the meeting along with OncLive
, register at gotoper.com